FreeFree RFPs on Craxy AI — no subscription required

Ready to bid on this RFP?

Sign up free to generate a complete proposal draft instantly — Craxy AI reads the RFP, drafts every section, and matches your past work.

Add to pipeline

Area of Interest under PHO ISO: ASCENT-IBO

Federal · Department of Health and Human ServicesDue Thursday, October 15, 2026
Client
Department of Health and Human Services
RFP Number
—
Posted
—
Category
US Federal
Budget
—
NAICS
541715
Set-aside
—
Contact
SEE DESCRIPTION SECTION
Email
[email protected]

Description

AI Generated

ARPA-H seeks proposals for the ASCENT-IBO initiative, aiming to accelerate safe clinical evaluation of ibogaine for better outcomes in Opioid Use Disorder. This opportunity builds upon a previous Special Notice and includes details for a Proposers Day event. Specific eligibility, evaluation criteria, budget information, and key dates are not provided in the source text.

Official SAM.gov notice

Solicitation number
ARPA-H-SN-26-158
Agency
Department of Health and Human Services
Buying office
National Institutes of Health › Advanced Research Projects Agency for Health (Arpa-H)
Notice type
Special Notice
Responses due
Oct 15, 2026, 5:00 PM ET
Posted on SAM.gov
Aug 5, 2026
NAICS
541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Product/service code
AN13
Contracting contact
SEE DESCRIPTION SECTION
[email protected]
Read the official notice description

See attached Special Notice ARPA-H-SN-26-158: Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better outcomes in OUD (ASCENT-IBO) This Special Notice builds upon ARPA-H-SN-26-156 and includes details related to a Proposers’ Day event.

Source: SAM.gov contract opportunities data (U.S. federal public data).

Incumbent

No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.

Market context

Awards in the same category (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)). This is not this requirement's award history.

Recent similar awards: Department of Health and Human Services, NAICS 541715

Vendor and awardValueEnds
FLOSONICS MEDICAL LLC75A50126C00006 · THE PURPOSE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF FLOPATCH FP120 WITH FLOPREDI$15.0MDec 31, 2031
LEIDOS BIOMEDICAL RESEARCH INC75N91026F00026 · INTEGRATED DMPK AND TOXICOLOGY PROFILING OF NCATS/TDB MEDICINAL CHEMISTRY LEAD CANDIDATES$1.7MSep 27, 2031
WESTAT, INC.75N94026F00001 · THE CONTRACTOR SHALL COORDINATE, MAINTAIN AND MANAGE NICHD PARTICIPATING SITES FOR IMPAACT$2.5MSep 27, 2031
LEIDOS BIOMEDICAL RESEARCH INC75N91026F00032 · CLINICAL MATERIAL TECHNOLOGY DEVELOPMENT AND PILOT MANUFACTURING$17.7MSep 23, 2031
LEIDOS BIOMEDICAL RESEARCH INC75N91026F00024 · IMPLEMENTATION AND CHARACTERIZATION OF IPSC-DERIVED CELL AND ORGANOID MODELS FOR INTEGRATI$1.3MSep 20, 2031

Top vendors in this category: Department of Health and Human Services, NAICS 541715, since Oct 1, 2023

2,246 contract awards in this NAICS over the period.

  1. 1. LEIDOS BIOMEDICAL RESEARCH INC$1.7B
  2. 2. THE MITRE CORPORATION$365.1M
  3. 3. WESTAT, INC.$212.7M
  4. 4. TECHNICAL RESOURCES INTERNATIONAL, INC.$136.4M
  5. 5. DUKE UNIVERSITY$110.8M

Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.

Source and verification

Original source

Craxy AI summarizes this opportunity from the original listing and available solicitation documents. Confirm submission instructions and amendments with the issuing source before responding.

1 cached source fileDocuments checked

Personalized fit score

Sign up free to see how well this opportunity fits your company — based on your saved profile.

Sign up to see your fit score